Special Issue "Stem Cell Therapy"
QuicklinksA special issue of Pharmaceuticals (ISSN 1424-8247).
Deadline for manuscript submissions: closed (31 May 2011)
Special Issue Editor
Guest Editor
Prof. Dr. Adrian P. Gee
Departments of Medicine and Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Plaza, BCM225, Houston, Texas 77030-3411, USA
Website: http://www.bcm.edu/genetherapy/faculty/gee.html
E-Mail: apgee@txccc.org
Special Issue Information
Submission
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed Open Access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 500 CHF (Swiss Francs). English correction and/or formatting fees of 250 CHF (Swiss Francs) will be charged in certain cases for those articles accepted for publication that require extensive additional formatting and/or English corrections.
Published Papers (2 papers)
  Pharmaceuticals 2011, 4(6), 848-879; doi:10.3390/ph4060848
Received: 2 May 2011; in revised form: 4 June 2011 / Accepted: 8 June 2011 / Published: 17 June 2011
Show/Hide Abstract
| Download PDF Full-text (370 KB) | Download XML Full-text |
|
Pharmaceuticals 2011, 4(10), 1355-1380; doi:10.3390/ph4101355
Received: 12 July 2011; in revised form: 21 September 2011 / Accepted: 10 October 2011 / Published: 21 October 2011
Show/Hide Abstract
| Download PDF Full-text (543 KB) | Download XML Full-text |
Planned Papers
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
Title: Stem Cells in Wound Healing
Type of Paper: Review
Authors: Marc Jeschke 1, Gerd G. Gauglitz 2
Affliations: 1 Department of Surgery, Division of Plastic Surgery University of Toronto, Toronto, Canada; E-Mails: majeschk@UTMB.EDU (M.J.)
2 Department of Dermatology and Allergy, Ludwig Maximilian University, Munich, Germany; gerd.gauglitz@med.uni-muenchen.de (G.G.G.)
Abstract: Cutaneous wound healing requires a well-orchestrated integration of the complex biological and molecular events of cell migration and proliferation, as well as extracellular matrix deposition, angiogenesis, and remodeling. Stem cells, due to their ability to differentiate into various tissue types by asymmetric replication thus represent a promising tissue repair strategy. A variety of sources, such as bone marrow, peripheral blood, umbilical cord blood, adipose tissue and skin/ hair follicles, have been utilized to isolate stem cells to modulate the healing response of acute and chronic wounds. Recent data have demonstrated the feasibility of autologous ASC therapy in cutaneous repair and regeneration. However, further research in order to solve the many questions on experimental and clinical application of stem cells in wound healing is necessary.
Last update: 17 January 2011